![CDER Conversation with Iilun Murphy](https://public4.pagefreezer.com:443/content/FDA/08-08-2023T13:42/http://www.fda.gov/files/styles/medium_3/public/CDER-conversation-Iilun-Murphy.png?itok=CZ9CPtX7)
CDER expert discusses research on patient perceptions of generic drugs
Aug 1 - Goals include how to best educate about generics and improve patient outcomes
Aug 1 - Goals include how to best educate about generics and improve patient outcomes
Aug 1 - Decreased levels of ascorbic acid may result in a range of complications
July 28 - Highlights FDA’s continued measures to address the overdose crisis
July 28 - Collaboration helps enable industry to reliably supply medicines for patients
July 26 - Program offers additional resources for drug development and manufacturing
July 24 - Topical drug is for adult and pediatric patients 2 years of age and older
PSAs inform consumers about the safe use and disposal of FDA-regulated products
The agency and HHS are working together to address the public health emergency
New initiative supports delivery of treatments for patients with a rare disease
Your source for the latest drug information.
Know the moment it happens.